Rankin Aubrey 4
4 · Revance Therapeutics, Inc. · Filed Apr 6, 2021
Insider Transaction Report
Form 4
Rankin Aubrey
DirectorPresident, Innovation & Tech
Transactions
- Sale
Common Stock
2021-04-05$28.28/sh−2$57→ 411,325 total(indirect: By Trust)
Holdings
- 174,302(indirect: By Trust)
Common Stock
- 79,776
Common Stock
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by Mr. Rankin.
- [F2]These shares are held by the Aubrey and Luanne Rankin Revocable Living Trust dated July 1, 2009. Mr. Rankin is a Trustee of this Trust.
- [F3]These shares are held by The Rankin Irrevocable Trust. Mr. Rankin is a Trustee of the Rankin Irrevocable Trust.